Obesity Trial, Recruiting NCT06511310 Sponsor: Joslin Diabetes Center Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06511310
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 18 and 70 years of age
  • People with a BMI above 19 kg/m² and a body weight under 250 kg
  • People who have had bariatric (weight loss) surgery and have since regained more than 10% of the weight they originally lost, with this regain happening between 1 and 5 years after their surgery — participants will need to report their own weight loss history and provide a copy of their surgery report
  • People who are in generally good health, with no conditions that could affect the trial results, as assessed by the trial doctor through medical history, physical examination, and lab tests
  • People who are willing and able to follow all study requirements for the full duration of the trial

Who may not be able to join:

  • People with Type 1 diabetes
  • People with nerve damage in their feet that causes loss of feeling
  • People who have donated blood in the last 2 months
  • People who are currently taking beta-blocker medications
  • People who are currently pregnant or breastfeeding
  • People with active heart or lung disease
  • People with severely high blood pressure (systolic above 160 mmHg or diastolic above 90 mmHg)
  • People who are unable to exercise for any reason
  • People for whom exercise testing would not be considered safe based on current guidelines from the American College of Sports Medicine
  • People with certain implants or metal objects in their body that are not compatible with MRI scanning, such as pacemakers, aneurysm clips, artificial heart valves, ear implants, or metal fragments in the eyes, skin, or body
  • People with a known structural abnormality in the brain, such as a tumour or a scar from a stroke
  • People with another neurological condition that could affect the study findings, such as multiple sclerosis
  • People with a history of heart disease, stroke, or heart failure
  • People with active disorders affecting the blood, kidneys, lungs, or liver
  • People currently receiving treatment for cancer
  • People with a current or recent history of alcohol or substance abuse
  • People with any serious or unstable illness that could make it difficult to follow the study procedures
  • People with claustrophobia or who are unable to tolerate an MRI scan
  • People with a body weight above 250 kg or a body width greater than 70 cm, due to the physical limits of the MRI scanner used in the study
  • People who are unwilling or unable to attend study visits, complete brain and thinking tests, or undergo MRI scanning
  • People who are left-handed

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Maria Vamvini, MD, Joslin Diabetes Center

Phone: 617-309-2400

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Joslin Diabetes Center
Registry
ClinicalTrials.gov
Start date
15 September 2025
Est. completion
1 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Changes in connectivity between brain areas following exercise training by using resting state functional MRI.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov